Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1989Mycoses

The In‐vitro Antifungal Spectrum of Itraconazole

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJ. Van CutsemRoyal Military Academy

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

J. Van Cutsem (1989) studied this question.

synapsesocial.com/papers/6a9041d5b71d06dae589dda9https://doi.org/10.1111/j.1439-0507.1989.tb02290.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Azole resistance inCandida albicans1986 · 103 citations
  2. 2Mutation in cytochrome P-450-dependent 14α-demethylase results in decreased affinity for azole antifungals1990 · 114 citations
  3. 3Antifungal relative inhibition factors: BAY 1–9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14–4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents1984 · 81 citations
  4. 4Preparation and antimycotic properties of derivatives of 1-phenethylimidazole1969 · 268 citations
  5. 5In vitro studies with R 51,211 (itraconazole)1984 · 133 citations